Provider review
Before treatment
Clinical Focus
Dual-pathway support
Tirzepatide
A dual-action GLP-1 and GIP option reviewed for appropriate weight-management candidates.
- Targets two appetite pathways at once
- May support weight-management goals
- Requires provider-led titration and monitoring
Start with a secure assessment
Answer health questions so a licensed provider can review whether Tirzepatide is clinically appropriate.
Check your eligibilityThe science
How Tirzepatide works in your body
A dual-action medication that engages GLP-1 and GIP pathways involved in appetite and metabolic signaling.
Activates the GIP receptor
Targets glucose-dependent insulinotropic polypeptide, a metabolic pathway involved in insulin and energy regulation.
Activates the GLP-1 receptor
At the same time, mimics GLP-1 - suppressing appetite and slowing how quickly food leaves your stomach.
Combined metabolic effect
The dual mechanism may support weight-management goals when treatment is clinically appropriate.
What to expect
What you can expect
Your provider introduces and adjusts treatment based on your medical history, response, and tolerance.
Month 1
Titration
Early response may begin as your provider introduces treatment and monitors tolerance.
Month 3
Progress
Your provider reviews appetite changes, side effects, and overall progress.
Month 6
Momentum
Continued treatment decisions are based on clinical response and tolerance.
Month 12
Maintenance
Ongoing care focuses on sustaining progress with provider guidance.
Individual response varies. Your provider will set expectations for your specific case.
What's included
Clinical support from assessment through follow-up.
Sawtooth keeps treatment connected to licensed provider review, secure communication, and coordinated fulfillment when a plan is authorized.
- Clinical review
- Your health profile is reviewed by a licensed medical professional before treatment is authorized.
- Provider oversight
- Dose guidance and safety monitoring stay connected to your medical profile.
- Medication coordination
- When prescribed, treatment is dispensed through a licensed pharmacy partner.
- Secure messaging
- Send questions to the care team from your account between clinical checkpoints.
- Progress check-ins
- Structured follow-ups help your provider understand response, tolerance, and next steps.
- Discreet shipping
- Approved treatment is shipped in private, temperature-aware packaging.
Compare options
Semaglutide
A single-agonist GLP-1 option with a familiar provider-supervised care pathway.
Read about SemaglutidePatient perspective
What people on Tirzepatide are saying.
612 Tirzepatide patients - 4.9/5 average
I had plateaued before discussing a different option. The care team helped me understand each adjustment.
David L.
Tirzepatide patient
I noticed my appetite felt different as treatment progressed, and I appreciated having my provider review what was changing.
Priya N.
Tirzepatide patient
I wanted a clinical option that still felt carefully supervised. My provider helped me think through whether it fit my history.
James K.
Tirzepatide patient
Safety, in plain language
No medication is right for everyone. Here's what to know.
Common side effects
Most common: nausea, decreased appetite, and digestive changes during titration. These are typically mild and resolve as your body adapts to each dose increase.
Who shouldn't take this
Not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, or if you are pregnant or breastfeeding. Full medical history is reviewed before any prescription.
Full safety information and prescribing details are reviewed during provider consultation before any treatment plan is authorized.
About treatment sourcing
What "compounded" means.
When a compounded option is clinically appropriate, it is prepared by a licensed U.S. compounding pharmacy. Your provider reviews your profile and determines whether a compounded or commercially available medication is the right fit.
Frequently asked
Questions worth answering before assessment.
Eligibility depends on your medical history, goals, current medications, and provider review. GLP-1 treatment generally requires weight-related clinical criteria and no contraindicating history.
A licensed medical professional reviews your responses and determines whether online treatment is clinically appropriate.
You will receive a clear next step. When online treatment is not appropriate, the care team may recommend in-person evaluation or another clinical path.
When prescribed, medication is shipped directly from a licensed pharmacy partner in discreet packaging.
Your provider reviews response and tolerance before any treatment adjustment.
Yes. Intake, checkout, consent, and portal flows are built for HIPAA-aligned privacy and secure handling of medical information.
Ready to see if Tirzepatide is right for you?
Start with Sawtooth's secure assessment. A licensed provider reviews your answers before any treatment plan is authorized.
Secure intakeLicensed provider reviewGuided next step